AstraZeneca (LON:AZN)

AstraZeneca (LON:AZN)

Share Price
6,327.00 p
77 (1.23 %)
Market Cap
£82,983.01 m
Proactive Investors - Run By Investors For Investors


AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease. AstraZeneca has over 67,000 empolyees and operates in over 100 countries with growing presence in important emerging markets.

Market: LSE:AZN
52-week High/Low: 6,540.00p / 5,110.00p
Sector: Pharma & Biotech
Market Cap: £82,983.01 m
col 3
col 4
col 5
col 6

AstraZeneca Timeline


AstraZeneca in cancer drug setback

The phase III trial involved patients with very late stage lung cancer where the disease had spread to other organs - in other words, the group was hard to treat
It said the US regulator had granted a priority review for its new cancer treatment and told investors a phase III trial of its diabetes medication delivered impressive results

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use